What Has Been The Evolution of the Pet Obesity Management Market in Recent Years?
The pet obesity management market has seen considerable growth due to a variety of factors.
• The pet obesity management market has witnessed strong growth in recent years. It is expected to grow from $8.9 billion in 2024 to $9.48 billion in 2025, at a compound annual growth rate (CAGR) of 6.6%.
This growth is driven by changes in pet feeding habits, reduced physical activity, breed genetics, the dynamics of human-animal bonds, and trends in veterinary healthcare.
What Are the Future Growth Projections for the Pet Obesity Management Market?
The pet obesity management market is expected to maintain its strong growth trajectory in upcoming years.
• The pet obesity management market is set for substantial growth, projected to reach $12.12 billion by 2029, with a CAGR of 6.3%.
The growth will be fueled by advances in veterinary nutrition, public awareness campaigns, innovative weight management products, and tailored exercise and diet programs. Key trends include greater demand for personalized diet plans, telemedicine for remote consultations, wearable health tech for pets, AI-driven nutrition guidance, and expanded weight management services in veterinary clinics.
What Are The Core Factors Supporting Growth In The Pet Obesity Management Market?
The surge in pet ownership is anticipated to fuel the expansion of the pet obesity management market. Pet ownership entails the obligation and attention given by individuals or families to meet the requirements, safety, and companionship of domesticated animals primarily kept for enjoyment rather than practical use. Changes in lifestyle, anthropomorphization of pets, and heightened disposable income are some contributory factors towards this rising trend of pet ownership. Pet obesity management becomes a pivotal element in pet ownership as it safeguards the health and welfare of the adopted animals, resulting in prolonged, joyous lives and diminished healthcare expenditures. For instance, the American Pet Products Association, a non-profit organization based in the US, revealed in October 2023 that 86.9 million US households owned a pet, accounting for 66% of households in 2022. Additionally, Animal Medicines Australia, an association representing animal health based in Australia, reported in November 2022 that 69% of households had pets in Australia in 2022. Consequently, the growing trend of pet ownership is stimulating the expansion of the pet obesity management market.
What Are The Major Segments Within The Global Pet Obesity Management Market?
The pet obesity management market covered in this report is segmented –
1) By Product: Drugs, Food Supplements
2) By Animal Type: Dogs, Cats, Other Animal Types
3) By Distribution Channel: Pet Specialty Stores, E-Commerce, Other Distribution Channels
Subsegments:
1) By Drugs: Appetite Suppressants, Fat Absorption Inhibitors, Metabolism Enhancers, Other Pharmaceutical Drugs
2) By Food Supplements: Fiber-Based Supplements, Probiotic Supplements, Omega-3 Fatty Acids Supplements, Protein-Based Supplements, Other Nutritional Supplements
Pre-Book The Pet Obesity Management Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Pet Obesity Management Industry?
Leading corporations in the pet obesity management industry are concentrating their efforts on the innovation of dynamic dietary solutions, for example, dietary metabolic canned and dry foods, as a response to the escalating issue of obesity in pets. These dietary metabolic canned and dry foods are specialized pet food items that aid pets in controlling their weight and confronting obesity problems via managed calorie consumption and nutritional equilibrium. To illustrate, Hill's Pet Nutrition Inc., a company based in the US known for its superior quality pet food and veterinary care solutions, introduced prescription diets in January 2024 such as prescription diet Z/D low-fat hydrolyzed soy canine, prescription diet C/D multicare low-fat canine, prescription diet gastrointestinal biome stress feline, and prescription diet C/D multicare stress feline. The objective of these formulations is to avert negative food reactions, enhance the health of skin in pets with sensitivities, and incorporate Hill's ActivBiome+ ingredient technology proven to rapidly boost digestive health by stimulating the gut microbiome.
Who Are the Key Players In The Pet Obesity Management Market?
Major companies operating in the pet obesity management market are:
• Pfizer Inc.
• Mars Inc.
• Zoetis Inc.
• Purina PetCare
• Royal Canin SAS
• Hill's Pet Nutrition Inc
• Drools Pet Food Pvt Ltd
• Virbac S.A.
• Blue Buffalo Pet Products Inc
• Dechra Pharmaceuticals plc
• Neogen Corp
• NOW Foods
• Merrick Pet Care Inc
• Natural Balance Pet Foods Inc
• Canidae Inc
• Nutro Inc
• FARMINA PET FOODS
• VioVet Ltd.
• Rolf C. Hagen Inc
• Delicate Care Ltd.
• Orijen Pet Foods
• ACANA HUNGARY LTD
What Is The Most Dominant Region In The Pet Obesity Management Market?
North America was the largest region in the pet obesity management market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet obesity management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
